Meetings

The role of international organisations in the elimination of viral hepatitis in Europe – Achievements, challenges and the way forward (Technical meeting, April 2023)

The role of international organisations in the elimination of viral hepatitis in Europe – Achievements, challenges and the way forward

Antwerp (Belgium)

5-6 April 2023

 

 

Meeting Objectives:

  • Provide an overview of the current viral hepatitis situation in Europe, in relation to the renewed WHO global health sector strategies 2022-2030
  • Discuss initiatives, achievements, best practices and challenges from international organizations in the prevention and control of viral hepatitis
  • Assess the needs to achieve elimination of viral hepatitis as a major public health threat by 2030 as set out in the new WHO Global Health Sector Strategies 2022-2030
  • Investigate potential collaborations
  • Discuss successes, good practices, issues and barriers to overcome and the way forward.

 

Background document (PDF, 702 kB)

Wednesday 5 April 2023 – Part 1

Introduction

Chairs: Pierre Van Damme and Angela Dominguez
09:00-09:30

Welcome and opening of the meeting

  • Welcome and opening 
  • Introduction of the participants

 

Session 1.1: WHO elimination goals – setting the scene

09:30-09:50

History of Global and European efforts to control Hepatitis B (pdf, 0.651Mb)

Mark Kane

09:50-10:10

Current situation & the new WHO Global Health Sector Strategies 2022-2030 (pdf, 5.737 Mb)

Philippa Easterbrook, WHO HQ (ONLINE)

10:10-10:30

How to apply the WHO Global Health Sector Strategies in Europe? (pdf, 2.657 Mb)

Marcelo Naveira, WHO Euro

10:30-10:40

 

Q&A and identify most important barriers

COFFEE BREAK 10:40-11:10

 

Session 1.2: Major barriers to overcome

Chairs: Vladimir Chulanov and Silvia Bino
11:10-11:30

ETAGE Working Group on Hepatitis B and progress of countries of the WHO European Region towards validation of hepatitis B control targets (pdf, 1.642 Mb)

Sandra Dudareva

11:30-11:40

Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C? (2020) (pdf, 1.048 Mb)

Graham Cooke

11:40-12:00

Survey results on the progress toward the WHO viral hepatitis elimination goals (pdf, 1.230 Mb)

Kate Turpie

12:00-12:10 Q&A and barriers to add

 

Session 1.3: Role of international organisations (Part 1)

12:10-12:50

European Centre for Disease Prevention and Control (ECDC) (pdf, 1.994 Mb)

Erika Duffell, ECDC

Centers for Disease Control and Prevention (CDC) (pdf, 1.145 Mb)

Senad Handanagic, CDC (ONLINE)

12:50-13:00 Q&A and barriers to add

LUNCH BREAK 13:00-14:00

 

Session 1.4: Role of International organisations (part 2)

Chairs: Maria Buti and Daniel Lavanchy
14:00-14:30

International Viral Hepatitis Elimination Meeting (IVEM) & The Task Force for Global Health – Coalition for Global Hepatitis Elimination (pdf, 466.201 Mb)

John Ward

Q&A and barriers to add

 

Session 1.5: Actions taken by patient organisations

14:30-15:30

World Hepatitis Alliance (WHA) (pdf, 1.675 Mb)

Cary James

European Liver Patients’ Association (ELPA) (pdf, 3.072 Mb)

Ivana Dragojević

Liver Patients International (LPI) (pdf, 0.170 Mb)

José Willemse

Q&A and barriers to add

COFFEE break 15:30-16u00

 

Session 1.6: Role of International organisations (part 3)

Chairs: Erika Duffell and Sandra Dudareva
16:00-17:20

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (pdf, 1.080 Mb)

Thomas Seyler (ONLINE)

Correlation Network (pdf, 3.506 Mb)

Roberto Pérez Gayo

International Centre for Migration, Health and Development (ICMHD) (pdf, 0.118Mb)

Manuel Carballo

UNITE (pdf, 9.025 Mb)

Ricardo Baptista Leite (ONLINE)

Q&A and barriers to add

 

Session 1.7: European projects highlighted

17:20-18:00

International projects working toward the elimination goals

  1. CORE “COmmunity REsponse to End Inequalities” (pdf, 0.643 Mb)

Oksana Panochenko

  1. BOOST (pdf, 0.867 Mb)

Roberto Pérez Gayo

  1. VH-COMSAVAC (pdf, 7.129 Mb)

Camila Picchio (ONLINE)

  1. RISE-Vac (mp4, 169.579 Mb)

Lara Tavoschi (PRE-RECORDED)

18:00-18:20

EU initiatives focusing on hepatitis (pdf, 0.953 Mb)

Katharina Ossenberg (ONLINE)

18:20-18:40

Ranking the identified barriers – general discussion

Organisations indicate which barriers they can help to overcome.

DINNER at 19:30

 

Thursday 6 April 2023 – Part 2

Session 2.1: Role of International organisations (part 4)

Chairs: Marcelo Naveira and Françoise Roudot-Thoraval
08:30-09:10

Center for Disease Analysis (CDA) (pdf, 2.190 Mb)

Devin Razavi-Shearer & Sarah Blach

European Society for Clinical Virology (ESCV) (pdf, 1.164 Mb)

Xavier López Labrador

09:10-09:30

European Association for the Study of the Liver (EASL) (pdf, 5.184 Mb)

Maria Buti

09:30-10:00

Associations Collaborating on Hepatitis to Immunise and Eliminate the Viruses in Europe (ACHIEVE) (pdf, 1.765 Mb)

Katharina Ossenberg (ONLINE)

10:00-10:20 Q&A and barriers to add

COFFEE break 10:20-11:00

 

Session 2.2: Groups discussions

Chairs: John Ward
11:00-12:00

Ranking the identified barriers – groups discussions 

Each group discusses how to handle one of the identified barriers, with a focus on the capacity of international organisations and how to work together better to improve the outcome.

12:00-12:30 Outcome of the groups discussions & general discussion

 

LUNCH 12:30-14:00 

Session 2.3: Meeting summary by David FitzSimons

Chairs: Mark Kane and Pierre Van Damme
14:00-14:40

Meeting summary (pdf, 0.211 Mb)

David FitzSimons

14:40-15:00 Closing remarks

 

Meeting report (375kB, Pdf) by David FitzSimons.